Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17513782rdf:typepubmed:Citationlld:pubmed
pubmed-article:17513782lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:17513782lifeskim:mentionsumls-concept:C0151744lld:lifeskim
pubmed-article:17513782lifeskim:mentionsumls-concept:C0031621lld:lifeskim
pubmed-article:17513782lifeskim:mentionsumls-concept:C0035126lld:lifeskim
pubmed-article:17513782lifeskim:mentionsumls-concept:C1545588lld:lifeskim
pubmed-article:17513782lifeskim:mentionsumls-concept:C0127400lld:lifeskim
pubmed-article:17513782lifeskim:mentionsumls-concept:C0441712lld:lifeskim
pubmed-article:17513782pubmed:issue11lld:pubmed
pubmed-article:17513782pubmed:dateCreated2007-5-21lld:pubmed
pubmed-article:17513782pubmed:abstractTextTLRs play a critical role in the induction of innate and adaptive immunity. However, TLRs have also been reported to mediate the pathophysiology of organ damage following ischemia/reperfusion (I/R) injury. We have reported that TLR4(-/-) mice show decreased myocardial injury following I/R; however, the protective mechanisms have not been elucidated. We examined the role of the PI3K/Akt signaling pathway in TLR4(-/-) cardioprotection following I/R injury. TLR4(-/-) and age-matched wild-type (WT) mice were subjected to myocardial ischemia for 45 min, followed by reperfusion for 4 h. Pharmacologic inhibitors of PI3K (wortmannin or LY294002) were administered 1 h before myocardial I/R. Myocardial infarct size/area at risk was reduced by 51.2% in TLR4(-/-) vs WT mice. Cardiac myocyte apoptosis was also increased in WT vs TLR4(-/-) mice following I/R. Pharmacologic blockade of PI3K abrogated myocardial protection in TLR4(-/-) mice following I/R. Specifically, heart infarct size/area at risk was increased by 98% in wortmannin and 101% in LY294002-treated TLR4(-/-) mice, when compared with control TLR4(-/-) mice. These data indicate that protection against myocardial I/R injury in TLR4(-/-) mice is mediated through a PI3K/Akt-dependent mechanism. The mechanisms by which PI3K/Akt are increased in the TLR4(-/-) myocardium may involve increased phosphorylation/inactivation of myocardial phosphatase and tensin homolog deleted on chromosome 10 as well as increased phosphorylation/inactivation of myocardial glycogen synthase kinase-3beta. These data implicate innate immune signaling pathways in the pathology of acute myocardial I/R injury. These data also suggest that modulation of TLR4/PI3K/Akt-dependent signaling pathways may be a viable strategy for reducing myocardial I/R injury.lld:pubmed
pubmed-article:17513782pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17513782pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17513782pubmed:languageenglld:pubmed
pubmed-article:17513782pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17513782pubmed:citationSubsetAIMlld:pubmed
pubmed-article:17513782pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17513782pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17513782pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17513782pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17513782pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17513782pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17513782pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17513782pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17513782pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17513782pubmed:statusMEDLINElld:pubmed
pubmed-article:17513782pubmed:monthJunlld:pubmed
pubmed-article:17513782pubmed:issn0022-1767lld:pubmed
pubmed-article:17513782pubmed:authorpubmed-author:LiYanYlld:pubmed
pubmed-article:17513782pubmed:authorpubmed-author:MaJingJlld:pubmed
pubmed-article:17513782pubmed:authorpubmed-author:WilliamsDavid...lld:pubmed
pubmed-article:17513782pubmed:authorpubmed-author:GaoXiangXlld:pubmed
pubmed-article:17513782pubmed:authorpubmed-author:KelleyJimJlld:pubmed
pubmed-article:17513782pubmed:authorpubmed-author:LiChuanfuClld:pubmed
pubmed-article:17513782pubmed:authorpubmed-author:BrowderI...lld:pubmed
pubmed-article:17513782pubmed:authorpubmed-author:HuaFangFlld:pubmed
pubmed-article:17513782pubmed:authorpubmed-author:HaTuanzhuTlld:pubmed
pubmed-article:17513782pubmed:authorpubmed-author:KaoRace LRLlld:pubmed
pubmed-article:17513782pubmed:issnTypePrintlld:pubmed
pubmed-article:17513782pubmed:day1lld:pubmed
pubmed-article:17513782pubmed:volume178lld:pubmed
pubmed-article:17513782pubmed:ownerNLMlld:pubmed
pubmed-article:17513782pubmed:authorsCompleteYlld:pubmed
pubmed-article:17513782pubmed:pagination7317-24lld:pubmed
pubmed-article:17513782pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:17513782pubmed:meshHeadingpubmed-meshheading:17513782...lld:pubmed
pubmed-article:17513782pubmed:meshHeadingpubmed-meshheading:17513782...lld:pubmed
pubmed-article:17513782pubmed:meshHeadingpubmed-meshheading:17513782...lld:pubmed
pubmed-article:17513782pubmed:meshHeadingpubmed-meshheading:17513782...lld:pubmed
pubmed-article:17513782pubmed:meshHeadingpubmed-meshheading:17513782...lld:pubmed
pubmed-article:17513782pubmed:meshHeadingpubmed-meshheading:17513782...lld:pubmed
pubmed-article:17513782pubmed:meshHeadingpubmed-meshheading:17513782...lld:pubmed
pubmed-article:17513782pubmed:meshHeadingpubmed-meshheading:17513782...lld:pubmed
pubmed-article:17513782pubmed:meshHeadingpubmed-meshheading:17513782...lld:pubmed
pubmed-article:17513782pubmed:meshHeadingpubmed-meshheading:17513782...lld:pubmed
pubmed-article:17513782pubmed:meshHeadingpubmed-meshheading:17513782...lld:pubmed
pubmed-article:17513782pubmed:meshHeadingpubmed-meshheading:17513782...lld:pubmed
pubmed-article:17513782pubmed:meshHeadingpubmed-meshheading:17513782...lld:pubmed
pubmed-article:17513782pubmed:meshHeadingpubmed-meshheading:17513782...lld:pubmed
pubmed-article:17513782pubmed:meshHeadingpubmed-meshheading:17513782...lld:pubmed
pubmed-article:17513782pubmed:meshHeadingpubmed-meshheading:17513782...lld:pubmed
pubmed-article:17513782pubmed:meshHeadingpubmed-meshheading:17513782...lld:pubmed
pubmed-article:17513782pubmed:meshHeadingpubmed-meshheading:17513782...lld:pubmed
pubmed-article:17513782pubmed:year2007lld:pubmed
pubmed-article:17513782pubmed:articleTitleProtection against myocardial ischemia/reperfusion injury in TLR4-deficient mice is mediated through a phosphoinositide 3-kinase-dependent mechanism.lld:pubmed
pubmed-article:17513782pubmed:affiliationDepartment of Surgery, East Tennessee State University, Johnson City, TN 37614, USA.lld:pubmed
pubmed-article:17513782pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17513782pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:17513782pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
entrez-gene:21898entrezgene:pubmedpubmed-article:17513782lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17513782lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17513782lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17513782lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17513782lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17513782lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17513782lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17513782lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17513782lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17513782lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17513782lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17513782lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17513782lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17513782lld:pubmed